[email protected]

Most recently CEO of Mind & Associates, Inc., Edward has been a senior level business executive, founder and Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic,

gynecologic and ENT companies. He has been responsible

for financial and clinical introductory oversight for Class I, II &

III Devices for minimally invasive techniques in all surgical

specialties, including RF therapy devices. Designer and

patent holder for the current transcatheter platform

technologies of ValveCure.

Internationally-recognized cardiologist, inventor, educator, author and one of the early pioneers of the angioplasty procedure. Author of over 180 research studies, clinical textbooks, and author of 24 granted patents. Scientific Advisory Board Chair for ValveCure; Professor of Medicine at the University of Arizona College of Medicine; Founder of the Phoenix Heart & Lung Center; Vascular Heart & Lung Associates, PC; Principal Investigator: 100+ medical device studies and 50 pharmaceutical studies.

[email protected]

Tom has extensive experience managing and participating in pre-clinical procedures and studies. Working with leading

cardiovascular technologies, including heart valves and other surgical and endovascular devices, Tom has collaborated

with prominent cardiovascular physicians in the U.S., Europe,

and China. As an employee and consultant, Tom has

completed pre-clinical projects for Edwards Lifesciences,

Ventrica, HeartPort, MiCardia, and 3F Therapeutics. 

[email protected]

CEO of NanoSomix, previously CEO Celula, Inc., Chairman & CEO of QuantumCor Inc., of which he has been a founder. John has also held senior level positions at Baxter Healthcare including President of the Immunotherapy Division and head of European R&D.